EXECUTIVE ENGAGEMENTS
POOL
INTERACTIONS
PARTICIPANTS
VALIDATIONS
COMPANIES
* Login for a full stack data experience
DATE
JAN 2023
TABLES
150
PAGES
486
EDITION
20
PRICE
USD 5450
CODE
MCP-1506
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
What`s New for 2023?
» Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
» Global competitiveness and key competitor percentage market shares
» Market presence across multiple geographies - Strong/Active/Niche/Trivial
» Online interactive peer-to-peer collaborative bespoke updates
» Access to our digital archives and MarketGlass Research Platform
» Complimentary updates for one year
Looking Ahead to 2023
The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Global Drug Discovery Technologies Market to Reach $85.9 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Drug Discovery Technologies estimated at US$49.9 Billion in the year 2020, is projected to reach a revised size of US$85.9 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Small Molecule Drugs, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$64.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biologics segment is readjusted to a revised 8.8% CAGR for the next 7-year period.
The U.S. Market is Estimated at $15.5 Billion, While China is Forecast to Grow at 10.1% CAGR
The Drug Discovery Technologies market in the U.S. is estimated at US$15.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$14 Billion by the year 2027 trailing a CAGR of 10.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 6.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.
SELECT PLAYERS
Affymetrix Inc.; Agilent Technologies, Inc.; Curia Global, Inc.; Astrazeneca plc; Bayer Healthcare AG; Bio-Rad Laboratories Inc.; Charles River Laboratories International Inc.; Evotec Ag; GYROS PROTEIN TECHNOLOGIES AB; Illumina, Inc.; Luminex Corporation; Merck KGaA; Molecular Discovery Ltd.; Novartis AG; Thermo Fisher Scientific Inc.
SEGMENTS
» Type (Small Molecule Drugs, Biologics) » Technology (High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology, Other Technologies) » End-Use (Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Uses)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Drug Discovery Technologies – Global Key Competitors Percentage Market Share in 2022 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E) |
A Prelude to Drug Discovery Technologies |
Impact of Pandemic on Drug Discovery Market |
Global Market Analysis and Prospects |
Global Drug Discovery Technologies Market Set to Witness Rapid Growth |
Regional Market Analysis |
Market Analysis based on Application |
Market Analysis based on End-User |
Competition |
Recent Market Activity |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Late-Stage Drug Failures Drives Demand for Drug Discovery Technolgies |
Exhibit 2: Average Cost of Drug Development (In Us$ Billion) in the US Since 1980s |
EXHIBIT 4: Factors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others |
Cell-based Assays Play a Critical Role in Drug Discovery |
TABLE 1: Cell-based Assays Market by Application (2020): Percentage Share Breakdown of Value Sales for Drug Discovery, ADME Testing, and Basic Research |
Major Types of Cell-Based HTS Assays for Drug Screening |
TABLE 2: Global Cell-based Assays Market by Segment (2020): Percentage Share Breakdown of Value Sales for Consumables, Instruments, Software, and Services |
High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays |
High Content Screening - Key Application Areas |
Technology Advances in Drug Discovery Processes |
Increased Demand of Biochips in Drug Discovery to Drive Market Growth |
Increased Demand for Personalized Medicine to Drive Drug Discovery Technologies Market |
EXHIBIT 3: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025 |
Proteomics and Genomics Drive Opportunities for Drug Discovery Technologies |
Proteomics Profiling to Expedite Drug Discovery |
Other Applications of Proteomics in Drug Discovery |
New Proteomics Technique to Aid Drug Screening & Biomarker Discovery |
Proteomic Approaches Gain Prominence in Cancer Drug Discovery |
Proteomics Technologies Used in Cancer Drug Discovery and Development |
Role of Proteomics in Oncology Biomarker Discovery |
Gaining Insights into COVID-19 & Drug Discovery with Proteomics |
Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction |
Using AI in Drug Discovery: The Latest Market Research |
High-throughput Screening (HTS) – A Key Drug Discovery Technology |
HTS: Making Use of a Smarter Approach to Hit Discovery |
Emerging Technologies in Drug Discovery and Development |
Targeted Drug Development and Discovery |
Significance of Advanced Clinical Sequencing for Drug Developers |
Metabolomics: An Emerging Trend in Drug Discovery |
Impact of ADME-Tox Screening on New Drug Discovery |
EXHIBIT 3: Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics |
Pharma Industry Renews Focus on Cost Optimization |
EXHIBIT 6: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2011 through 2020 |
China and India: Hot Spots for R&D Investment |
EXHIBIT 8: World R&D Market by Geographic Region (2020): Percentage Breakdown of R&D Spending for Asia, Europe, Middle East & Africa, North America and South America |
Omics Technology to Witness Rapid Growth |
Adoption of Omics-based Technologies |
Increasing Demand for 3D Cell Culture in Drug Discovery |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Drug Discovery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Drug Discovery Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Small Molecule Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Small Molecule Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Small Molecule Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Bioinformatics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pharmacogenomics & Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Pharmacogenomics & Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Pharmacogenomics & Pharmacogenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Nanotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Nanotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Nanotechnology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027 |
III. MARKET ANALYSIS |
UNITED STATES |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E) |
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
USA Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
USA 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
CANADA |
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Canada Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Canada 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
JAPAN |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E) |
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Japan Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Japan 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
CHINA |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E) |
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
China Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
China 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
EUROPE |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E) |
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2020 through 2027 and % CAGR |
Europe Historic Review for Drug Discovery Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Drug Discovery Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Europe Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Europe 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
FRANCE |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E) |
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
France Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
France 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
GERMANY |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E) |
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Germany Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Germany 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
ITALY |
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Italy Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Italy 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
UNITED KINGDOM |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E) |
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
UK Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
UK 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of Europe Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of Europe 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
ASIA-PACIFIC |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Asia-Pacific Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Asia-Pacific 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2012, 2021 & 2027 |
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2020 through 2027 and % CAGR |
Rest of World Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2012 through 2019 and % CAGR |
Rest of World 15-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2012, 2021 & 2027 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com